LABEST 2022 Main Track and Professor Spotlights are now viewable on YouTube
Make sure to subscribe when you get there!
LATEST UPDATE: LABEST 2022 is SOLD OUT !!!
A LImited Number of Walk Up tickets may be available the day of the event starting at 5/26 at 8AM but not guaranteed.
View Full Online Program, Poster Entries and Professor Spotlights Here.
Amir Naiberg has been the associate vice-chancellor and CEO and president of UCLA Technology Development Group since 2016, when he joined from having led Yeda, the tech transfer arm of Weizmann Institute of Science.
In memoriam: Brian Roe, 41, director at UCLA Technology Development Group
Marivi Valcourt | April 5, 2022
Brian Roe, director of the industry research and material transfer team at the UCLA Technology Development Group, died March 23. He was 41.
24 scientists and researchers receive awards from Technology Development Group
Marivi Valcourt | April 4, 2022
Twenty-four researchers at UCLA have been named recipients of awards from the 2021 UCLA Innovation Fund Biomedical Competition.
Potential glioblastoma treatment has roots in UCLA graduate research
Recently approved for clinical trials, ERAS-801 was developed by a trio of faculty members
Marivi Valcourt | March 15, 2022
A potential new treatment for glioblastoma that recently received approval for clinical trials not only was developed by three UCLA faculty members but also traces its roots back to 2005, when one of the researchers was a UCLA graduate student.
UCLA Considers Underserved Populations When Licensing Medical Research Discoveries
UCLA is committed to its public-service mission of transparent and equitable biomedical research that enhances understanding of disease and leads to new treatments. Discoveries made in UCLA’s laboratories are available as medications worldwide.
Please see our listing here